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Objective: To establish “normal” ranges for synovial thickness and effusion detected by ultrasound (US)
and to determine cut-offs associated with knee pain (KP) and radiographic knee osteoarthritis (RKOA) in
the community.
Methods: 147 women and 152 men 40 years old were randomly selected from the Nottingham KP and
Related Health in the Community (KPIC) cohort (n ¼ 9506). The “normal” range was established using
the percentile method in 163 participants who had no KP and no RKOA. Optimal (maximum sensitivity
and speciﬁcity) and high speciﬁcity (90%) cut-offs were established using receiver operating character-
istic (ROC) curve analysis in a comparison between people with both KP and RKOA and normal controls.
Results: Effusion and synovial hypertrophy differed by gender but not by age or laterality, therefore
gender-speciﬁc reference limits were estimated. However, the “normal” ranges between men and
women were similar for effusion (0e10.3 mm vs 0e9.8 mm), but different for synovial hypertrophy (0
e6.8 mm vs 0e5.4 mm). Power Doppler Signal (PDS) in the healthy controls was uncommon (1.2% in men
and 0.0% in women). The optimal cut-off was 7.4 mm for men and 5.3 mm for women for effusion, and
3.7 and 1.6 for hypertrophy respectively. The high speciﬁcity cut-off was 8.9 for men and 7.8 for women
for effusion, and 5.8 and 4.2 for hypertrophy respectively.
Conclusions: US effusion and synovial hypertrophy but not PDS are common, but differ by gender, in
community-derived people without painful knee OA. Currently used cut-offs for abnormality need
reappraisal.
© 2018 The Authors. Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).Introduction
Knee osteoarthritis (OA) is a major cause of chronic pain and
impaired function in older adults1,2. Knee OA is a common complex
joint disorder that involves all joint tissues including hyaline
articular cartilage, ﬁbrocartilaginous menisci, synovium, bone, lig-
aments and muscle3e5. These pathological changes can be detected: W. Zhang, Academic Rheu-
ttingham NG5 1PB, UK.
Sarmanova), michelle.hall@
ham.ac.uk (G.S. Fernandes),
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M. Doherty), weiya.zhang@
r Ltd on behalf of Osteoarthritis Re
Thresholds of ultrasound syn
artilage, https://doi.org/10.10using various imaging techniques such as radiographs, ultrasound
(US) and magnetic resonance imaging (MRI). Because people with
knee OA show wide variability of presentation with respect to
compartmental involvement and degree of bony changes and
inﬂammation, it could prove possible to use modern imaging
techniques to identify potential subgroups/phenotypes in the het-
erogeneous population of people with knee OA6.
US is a non-invasive imaging technique that is used commonly
to detect inﬂammatory changes in joints. It is relatively inexpen-
sive, widely available and has no radiation burden or contraindi-
cations7. Over the last two decades a number of technical advances
have improved US imaging of joints and soft tissues, increasing its
utility for assessment of musculoskeletal conditions8. US detection
of synovial effusion and synovial hypertrophy in knees is more
sensitive than clinical examination9,10, correlates well withsearch Society International. This is an open access article under the CC BY license
ovial abnormalities for knee osteoarthritise a cross sectional study in
16/j.joca.2018.09.018
A. Sarmanova et al. / Osteoarthritis and Cartilage xxx (xxxx) xxx2histological ﬁndings11,12 and correlates well with MRI in visualising
effusion13,14. However, evidence regarding “normal” values for
effusion and hypertrophy in the general population is limited15. For
example, the only study to provide reference values for effusion
was based on a group of healthy volunteers aged 20e60 years old
(n ¼ 102)16, which is a low age range for OA, and no population
studies have reported normal values for synovial hypertrophy or
prevalence of Power Doppler signal (PDS).
A few studies have attempted to identify an optimal threshold
(maximum sensitivity and maximum speciﬁcity) or scoring system
for US synovial changes (USSCs) in knee OA. For example, a EULAR-
ESCISIT multi-centre study involving 600 individuals with knee OA
tested different cut-offs of synovial hypertrophy (2 mm or
4 mm) and effusion (4 mm) against radiographic severity and
knee effusion on clinical examination17. The diagnostic accuracy of
these cut-offs was low, and it was recommended that a threshold of
4 mm be used for both features18. Two European Multicentre
Studies also found that thresholds varied depending upon knee
positioning. While Terslev et al.19 found the optimal cut-off
(maximum sensitivity and maximum speciﬁcity) for knee effusion
detected in the neutral position with quadriceps contraction was
3.2 mm, Mandl et al.20 showed that the optimal cut-off for effusion
at 30 degrees of ﬂexion was 3.6 mm. However, the comparison in
these studies was made between normal and abnormal knees in
people with knee OA or other rheumatic conditions, hence the
thresholds between knee OA and the general population remain
unknown. Furthermore, none of the existing recommendations for
scoring USSC have considered age, gender or laterality. Interest-
ingly, the EULAR-ESCISIT study in people with knee OA noted that
women had fewer joint effusions than men [OR 0.62, no conﬁdence
interval (CI) reported]18 but still recommended the same threshold
(4 mm) for men and women. Differences in joint anatomy, physi-
ology, pain perception and risk of incidence and progression of OA
between genders provides a clear physiological basis for examining
whether there is a difference in USSCs between men and women21.
We therefore undertook this study in a random sample of
community-derived men and women aged over 40 years who are
participating in a prospective cohort22 to: [1] examine the normal
ranges of USSCs and their distributions by age, gender and laterality
in the healthy participants; and [2] establish optimal cut-offs for
symptomatic knee OA compared with healthy controls.
Methods
Participants for this cross sectional study were selected from the
Knee Pain and Related Health in the Community Study (KPIC)22, an
ongoing prospective cohort study in Nottingham, UK that included
at baseline 9506men andwomen aged40 years. For convenience,
participants for the KPIC were selected from the primary care
practices closest to Nottingham City Hospital. To ensure that this
set is representative of the whole population we compared the ﬁve
selected practices with the seven unselected practices and the
whole population and found no difference in terms of age, gender
and bodymass index (BMI) (Appendix 1). In selected practices 1662
participants replied to the follow-up questionnaire, of them 1284
(763 women, 521 men) agreed to receive information about further
projects. They were stratiﬁed by gender and a random sample was
taken from each group regardless of their KP/OA status (Fig. 1). The
characteristics of participants invited for the current study
(n ¼ 500), and those who did reply (n ¼ 360) are shown in
Appendix 2, and characteristics of the ﬁnal sample (n ¼ 299) are
shown in Appendix 3.
Age, gender, height, weight and KP status were self-reported in
the postal questionnaire. Current KP was deﬁned as pain on most
days of the past month23,24 (later referred as KP).Please cite this article as: Sarmanova A et al., Thresholds of ultrasound syn
the general population, Osteoarthritis and Cartilage, https://doi.org/10.10Participants were invited to attend for clinical assessments,
including US and radiographs of both knees at Nottingham City
Hospital.
1. US assessment
US examination was performed by two assessors (MH, AS), us-
ing the Toshiba Aplio SSA-770A machine with a multi-frequency
(7e12 MHz) linear array transducer. The same equipment and
software were used throughout the study. The supra-patellar recess
and medial and lateral tibio-femoral spaces were assessed with
knee ﬂexion of approximately 20e30. USSCs were deﬁned ac-
cording to OMERACT-7 deﬁnitions (Appendix 4)25. Depth of syno-
vial thickness (hypertrophy) and effusionwere each measured on a
continuous scale at their maximal diameter in millimetres using
the longitudinal axis. PD assessment was focused on areas of sy-
novial hypertrophy and recorded as absent or present. All mea-
surements were made in real time. Only one value per joint was
recorded for each US feature (the maximum value across the three
areas scanned). The inter-observer and intra-observer reliability
test results were reported previously26.
2. Radiographic knee OA (RKOA) assessment
Bilateral weight-bearing semi-ﬂexed posterioreanterior tibio-
femoral views using a Rosenberg template and 30 ﬂexion skyline
patello-femoral views were undertaken using standardised pro-
tocols22. The Nottingham logically derived line drawing atlas
(LDLDA)27,28 was used to score joint space narrowing (JSN) in
medial and lateral tibio-femoral and medial and lateral patello-
femoral articulations (each scored 1 to 5) and osteophytes (at
eight sites in the three compartments, each scored 0e5). The scores
for all three compartments, ignoring 1 values for JSN (i.e., joint
space widening), were summated as a global score for each knee.
Presence of RKOA was deﬁned as deﬁnite JSN (grade 2) plus deﬁ-
nite osteophyte (grade 2) in any compartment (tibiofemoral or
patellofemoral). This deﬁnition of deﬁnite osteophyte and deﬁnite
narrowing accords with the pathological deﬁnition of OA which
requires both deﬁnite focal loss of hyaline cartilage and deﬁnite
associated bone change29. Symptomatic RKOA was deﬁned as cur-
rent KP plus RKOA. Alternative deﬁnition of symptomatic RKOA was
as current KP plus Kellgren and Lawrence (K&L) grade 2 in any
compartment30.Statistical analysis
1. Sample size
Sample size was calculated using the formula for a single cross-
sectional study31. A population-based study conducted by Abraham
et al.32 reported prevalence of US-detected effusion at 24%. There-
fore, sample size required for this cross sectional study is 280
assuming the error margin d ¼ 3%. This number also corresponds
with the recommended minimum sample size for establishing
reference intervals (n ¼ 120 per group)33.
2. “Normal” range
The “normal” range was established in the healthy participants
who had no KP and no RKOA34. We used 0 as the low limit and 95th
percentile as the upper limit to deﬁne the normal range of US
effusion and synovial hypertrophy. The 95% CI for the upper limit
was calculated using the distribution-free method as data were not
normally distributed (Hahn and Meeker, 2011).ovial abnormalities for knee osteoarthritise a cross sectional study in
16/j.joca.2018.09.018
Fig. 1. Recruitment of participants in the “Knee synovial changes detected by US in the general population: cross sectional study” (by the 28th of November 2016).
A. Sarmanova et al. / Osteoarthritis and Cartilage xxx (xxxx) xxx 33. Optimal threshold
The discrimination ability (i.e., ability to separate cases and
controls) of each US featurewas determined in a case control study,
where people with symptomatic RKOA (deﬁned above) were clas-
siﬁed as cases and those with neither KP nor RKOA were classiﬁed
as controls. Standard diagnostic accuracy measures (e.g., sensitivity
and speciﬁcity, likelihood ratios (LRs)) and ROC statistics were
calculated35,36.
Two cut-offs were established in this study:
 An optimal cut-off with the maximum sensitivity and
speciﬁcity according to the Youden index: J ¼ Maximum
(Sensitivity þ Speciﬁcity  1)36.
 A cut-off with a relatively high speciﬁcity of 90% to ensure the
minimum misdiagnosis.Please cite this article as: Sarmanova A et al., Thresholds of ultrasound syn
the general population, Osteoarthritis and Cartilage, https://doi.org/10.10We also examine the sensitivity, speciﬁcity and LR etc for the 4-
mm cut-off recommended by EULAR18. Further details regarding
the statistical methods can be found in Appendix 5.
Missing data are presented in Appendix 6. All analyses were
undertaken using SAS software v9.4.
Results
Demographic and clinical characteristics of the study population
Of the total 299, 163 individuals had no KP and no RKOA e
healthy controls and 44 individuals had symptomatic RKOA. Apart
from age, the healthy controls were different from symptomatic
RKOA for gender, BMI, KP, radiographic score and all three US fea-
tures (Table I). The prevalence of PDS was 0.65% (1.2% in men and
0.0% inwomen) in the healthy controls, whereas it was 7% (14.3% inovial abnormalities for knee osteoarthritise a cross sectional study in
16/j.joca.2018.09.018
A. Sarmanova et al. / Osteoarthritis and Cartilage xxx (xxxx) xxx4men and 3.6% inwomen) in the symptomatic RKOA (P¼ 0.0083). As
the frequency of the signals was near zero in the healthy control,
there is no need to establish a normal range and cut-off.
In the healthy controls both effusion and synovial hypertrophy
did not associate with age (Appendix 7), but were greater in men
than in women (median effusion 4.7 mm in men vs 3.4 mm in
women, P ¼ 0.0035; median synovial hypertrophy 2.0 mm in men
vs 0 mm in women, P ¼ 0.0012). The gender difference remained
signiﬁcant after adjustment for height for synovial hypertrophy
(P ¼ 0.019), but not for effusion (P > 0.05). There was no difference
between right and left knees in bothmen and women (all P > 0.05).
The distribution of effusion and synovial hypertrophy mea-
surements with a superimposed normal curve in men and women
are shown in Appendix 8-1. Because of the high number of zero-
values the transformation attempts were unsuccessful (Appendix
8-2). Therefore, original data were used for the analysis.
“Normal” range
The normal ranges for effusion and synovial hypertrophy inmen
and women are shown in Table II and Figure 3. The “normal” range
of effusion and synovial hypertrophy in a “healthy” sample deﬁned
as no KP plus K&L grade 0e1 alternatively are presented in
Appendix 9.
Different cut-offs: exploring misclassiﬁcation rate
EULAR cut-off
We examined how well the EULAR threshold of 4 mm18 sepa-
rates cases and controls. For effusion the sensitivity of this
threshold was 93% and 79% for men and women, respectively but
the speciﬁcity was only 39% and 61%, respectively. Consequently,
60% of men and 39% of women without the disease were mis-
classiﬁed as having the disease (false-positive), and 7% of men and
21% of women with the disease were misclassiﬁed as non-disease
(false-negative). For hypertrophy the sensitivity was only 64% and
50% formen andwomen, respectively, while the speciﬁcity was 78%
and 89%, respectively. The proportion of men and women with
false-positive and false-negative results is shown in Appendix 10.
Optimal threshold
Based on the maximum value of Youden Index the optimal
threshold for effusion was 7.4 mm in men and 5.3 mm in women,
and for synovial hypertrophy it was 3.7 for men and 1.6 for women
(Table III and Fig. 3). These new cut-off points were characterised byTable I
Characteristics of the study population
Healthy contro
N 163
Age (years), mean (SD) 65.73 (9.26)
Women, n (%) 75 (46.01)
BMI (kg/m2), mean (SD) 25.30 (3.59)
Effusion right, median (IQR) 4 (2.5e6.7)
Synovial hypertrophy right, median (IQR) 0 (0e3.5)
Power Doppler Signal right, n (%) 1 (0.65)
Knee pain every, n (%) 58 (35.58)
Knee pain in the past 12 months, n (%) 13 (7.98)
Global radiographic score (0e60)k, mean (SD) 2.06 (2.50)
Note: * P-values: t test for age, BMI, global radiographic score, ManneWhitney U test for
speciﬁed.
SD e standard deviation; IQR e inter-quarter range; NRS e numerical rating scale 0e10
y Pain in or around a knee on most days for at least a month.
z No current knee pain (knee pain onmost days of the past month) and no RKOA (deﬁni
or patellofemoral)).
x Knee pain on most days of the past month plus RKOA (deﬁnite JSN (grade 2) plus de
k Summated score for osteophytes and JSN (NLDLDA scoring system) in tibiofemoral a
Please cite this article as: Sarmanova A et al., Thresholds of ultrasound syn
the general population, Osteoarthritis and Cartilage, https://doi.org/10.10the maximum sensitivity and maximum speciﬁcity of the tested US
features (Fig. 2).
Threshold with high speciﬁcity
For effusion the threshold corresponding with speciﬁcity of 90%
was 8.9 mm in men and 7.8 mm in women (Table III and Fig. 3). For
synovial hypertrophy the threshold corresponding with high
speciﬁcity was 5.8 in men and 4.2 inwomen. The LRþ for these cut-
offs was close to 5 (higher than LRþ for other cut-offs).
All three cut-off values with corresponding sensitivity, speci-
ﬁcity, and other measures of diagnostic accuracy are presented in
Table III and Figure 3.
Discussion
To our knowledge, this is the ﬁrst population-based study in an
age-range suitable for knee OA to investigate reference values and
the cut-off of USSCs for identiﬁcation of symptomatic RKOA. The
main ﬁndings are: [1] USSCs are different betweenmen andwomen
therefore gender-speciﬁc reference limits should be established; [2]
the “normal” range for effusion is between 0e10.3 mm for men and
0e9.8 mm for women and the “normal” range for synovial hyper-
trophy is between 0e6.8mm formen and 0e5.4mm forwomen; [3]
the optimal cut-off that may be used to screen people with abnor-
mally increased synovial changes in symptomatic RKOA is 7 mm for
men and 5mm forwomen for effusion, and 4mm formen and 2mm
forwomen for hypertrophy; [4] themore stringent cut-off with high
speciﬁcity that may be more appropriate for deﬁning “active” cases
for RCTs and for identifying a more inﬂammatory (endo)phenotype
of symptomatic RKOA is 9 mm for men and 8 mm for women for
effusion, and 6 mm men and 4 mm for women for hypertrophy.
No previous studies have reported reference values for US in the
general population aged over 40 years old. Recently a large study of
D'Agostino et al.37 reported a high prevalence of USSCs in a
population-based cohort aged >60 years old (effusion present in
69.7% and synovial hypertrophy in 53.1%). However, no data on
distribution (mean values, minemax range) were reported.
Nevertheless, the high prevalence of US features in this cohort is in
line with our results. The “normal” range was established for men
and women separately as we found signiﬁcantly higher values of
synovial hypertrophy in men compared to women. Our results are
in line with the study of D'Agostino et al.18 that reported that
women had fewer joint effusions than men (OR 0.62). The
subgroup-based “normal” range provides more sensitive and spe-
ciﬁc results and improves clinical application38. Moreover, thelz Symptomatic RKOAx P-value*
44
67.23 (9.00) 0.3380
29 (65.91) 0.0192
29.73 (6.00) <0.0001
8.9 (5.8e12.8) <0.0001
4.45 (1.9e8.4) <0.0001
3 (7.14) 0.0083
44 (100.0) <0.0001
41 (93.18) <0.0001
16.47 (7.13) <0.0001
effusion and synovial hypertrophy, and chi-square for categorical unless otherwise
.
te JSN (grade 2) plus deﬁnite osteophyte (grade 2) in any compartment (tibiofemoral
ﬁnite osteophyte (grade 2) in any compartment (tibiofemoral or patellofemoral)).
nd patellofemoral joints (medial and lateral compartments).
ovial abnormalities for knee osteoarthritise a cross sectional study in
16/j.joca.2018.09.018
Table II
“Normal” range of effusion and synovial hypertrophy in mm in people without KP and RKOA
Men (n ¼ 88) Women (n ¼ 75)
Min Max Median (IQR) Normal range
(0e95th percentile)
Min Max Median (IQR) Normal range
(0e95th percentile)
Effusion 0 14.6 4.7 (3.0; 7.2) 0e10.3 0 13.3 3.4 (2.2; 5.5) 0e9.8
Synovial hypertrophy 0 8.2 2.0 (0; 3.8) 0e6.8 0 8.0 0 (0; 2.3) 0e5.4
Note: The 95% CIs for the upper limit of the normal range, i.e., the 95th percentile for effusion were 9.3 mme14.6 mm in men and 7.4 mme13.3 mm in women; and those for
synovial hypertrophy were 5.8 mme8.2 mm in men and 3.9 mme8.0 mm in women.
P-values for the difference in effusion and synovial hypertrophy between men and women were 0.0035 and 0.0012, respectively (Mann Whitney U Test).
A. Sarmanova et al. / Osteoarthritis and Cartilage xxx (xxxx) xxx 5larger values in men align with thicker cartilage in men and the
development of different ranges in men and women for radio-
graphic assessment using the (LDLDA)27,28.
It is important to recognise the difference between the reference
intervals and cut-offs. The reference interval is the range of values
that would reﬂect a biological variability of a diagnostic marker in a
healthy population. Typically, reference intervals are referred to as
“normal” values and therefore any test result would be interpreted
relative to its upper (or lower) limit. However, for many diagnostic
tests “normal” values have been deﬁned on the basis of analysis ofFig. 2. ROC curves for a continuous value of effusion (upper row) and hypertrophy (bottom r
from pain-free people without ROA. The red dot represents an optimal cut-off value with t
Please cite this article as: Sarmanova A et al., Thresholds of ultrasound syn
the general population, Osteoarthritis and Cartilage, https://doi.org/10.10clinical outcomes39. Cut-offs (“decision limits”) depend on the type
of pathological condition being considered and the type of decision
to be made40. For example, the 97.5 percentile for cholesterol
concentration in the general population lies between 280 and
300 mg dL1 (7.25e7.77 mmol L1), while the cut-off associated
with moderate and high risks for the development of cardiovas-
cular disease are 200 mg dL1 (5.18 mmol L1), and 240 mg dL1
(6.22 mmol L1), respectively (National Cholesterol Education
Program (NCEP) Expert Panel41). Therefore, in this study in addition
to the reference intervals for effusion and hypertrophy in pain-freeow) in men (left) and women (right) for discriminating people with symptomatic RKOA
he highest Youden Index.
ovial abnormalities for knee osteoarthritise a cross sectional study in
16/j.joca.2018.09.018
Fig. 3. A summary of normal values, high speciﬁcity and optimal thresholds for effusion and synovial hypertrophy.
A. Sarmanova et al. / Osteoarthritis and Cartilage xxx (xxxx) xxx6participants without RKOA, we calculated cut-offs corresponding
with the presence of symptomatic RKOA. Because of the large
overlap between people with and without symptomatic RKOA, we
applied two different methods to establish a cut-off. Firstly, we
calculated an optimal cut-off using the Youden Index. This method
has beenwidely used to identify an optimal cut-off with maximum
sensitivity and speciﬁcity42,43. Secondly, we calculated a threshold
corresponding with pre-deﬁned speciﬁcity at 90% to identify a
subgroup of peoplewith symptomatic RKOAwho are different from
the healthy population. These cut-offs corresponded with the
highest likelihood ratio of a positive test result (“LRþ” z 5). This
subgroup is more likely to represent an “inﬂammatory” phenotype.
In our study the prevalence of PDS was very low in the healthy
control group and higher in people with symptomatic RKOA. TwoPlease cite this article as: Sarmanova A et al., Thresholds of ultrasound syn
the general population, Osteoarthritis and Cartilage, https://doi.org/10.10studies previously reported prevalence of PDS in the general pop-
ulation37,44. In the study by Hall et al.44 the prevalence of PDS in
pain-free people without RKOA (n ¼ 90) was 2.2% and in people
with symptomatic RKOA 16.2%, which is in linewith our ﬁndings. In
the study by D'Agostino et al.37 the prevalence of PDS was 31.8% in
the general population. However, this cohort (n ¼ 433) was older
(range 60e98) and the prevalence of KP was 31.6%.
There are several limitations to this study. Firstly, KPIC is a
questionnaire-based cohort study for KP, therefore, participants
with KP may be more likely to respond to the study (response
bias). Secondly, sampling bias cannot be discounted. Although we
randomly selected participants for this study from the KPIC
cohort, people with KP are generally more willing to participate in
a clinical assessment (prevalence of KP was 21% in non-ovial abnormalities for knee osteoarthritise a cross sectional study in
16/j.joca.2018.09.018
Table III
Sensitivity, speciﬁcity, positive and negative likelihood ratio of synovial effusion and hypertrophy for the diagnosis of knee abnormality (KP plus RKOA) according to the
different thresholds
Criterion Description Cut-off
(mm)
Positive in KP þ
RKOA* group,
n/N (%)
Positive in
controls,
n/N (%)
Sensitivity
(95% CI)
Speciﬁcity
(95% CI)
J LRþ LR FPP FNP
Effusion
Men EULAR 4 13/14 (92.86) 54/88 (61.36) 0.93 (0.66; 1.00) 0.39 (0.28; 0.50) 0.31 1.51 0.18 0.81 0.03
Optimal 7.4 11/14 (78.57) 19/88 (21.54) 0.79 (0.49; 0.95) 0.78 (0.68; 0.86) 0.57 3.64 0.27 0.63 0.04
High speciﬁcity 8.9 7/14 (50) 9/88 (10.23) 0.50 (0.23; 0.77) 0.90 (0.81; 0.95) 0.40 4.89 0.56 0.56 0.08
Women EULAR 4 22/28 (78.57) 29/75 (38.67) 0.79 (0.59; 0.92) 0.61 (0.49; 0.72) 0.40 2.03 0.35 0.57 0.12
Optimal 5.3 14/28 (50) 8/75 (10.67) 0.75 (0.55; 0.89) 0.73 (0.62; 0.83) 0.48 2.81 0.34 0.49 0.11
High speciﬁcity 7.8 15/28 (53.57) 7/75 (9.33) 0.54 (0.34; 0.72) 0.91 (0.82; 0.96) 0.44 5.74 0.51 0.32 0.16
Hypertrophy
Men EULAR 4 9/14 (64.29) 19/88 (21.59) 0.64 (0.35; 0.87) 0.78 (0.68; 0.86) 0.43 2.98 0.46 0.68 0.07
Optimal 3.7 12/14 (85.71) 24/88 (27.27) 0.86 (0.57; 0.98) 0.73 (0.62; 0.82) 0.58 3.14 0.20 0.67 0.03
High speciﬁcity 5.8 8/14 (57) 9/88 (10.23) 0.57 (0.29; 0.82) 0.90 (0.81; 0.95) 0.47 5.59 0.48 0.53 0.07
Women EULAR 4 21/28 (75) 20/75 (26.67) 0.50 (0.31; 0.69) 0.89 (0.80; 0.95) 0.39 4.69 0.56 0.36 0.17
Optimal 1.6 21/28 (75) 21/75 (28) 0.75 (0.55; 0.89) 0.72 (0.60; 0.82) 0.47 2.68 0.35 0.50 0.11
High speciﬁcity 4.2 14/28 (50) 7/75 (9.33) 0.50 (0.31; 0.69) 0.91 (0.82; 0.96) 0.41 5.36 0.55 0.33 0.17
Abbreviations: J e Youden Index; “LR” e likelihood ratio of a negative test result; FPP e false positive probability; FNP e false negative probability.
* According to NDLA for current, optimal and high sensitivity thresholds (NLDLDA).
A. Sarmanova et al. / Osteoarthritis and Cartilage xxx (xxxx) xxx 7responders and 30% in responders, P ¼ 0.036, Appendix 3).
Sampling bias also could account for the unrepresentativeness of
the younger age group (less than 55) as the working age popu-
lation is less likely to respond to the invitation. Thirdly, we used
“current KP” deﬁnition to divide our sample into those with and
without KP in order to determine the decision threshold for both
US values. This deﬁnition is one of the clinical criteria for knee OA
according to the American College of Rheumatology (ACR)45. A
study by O'Reilly et al.24 which compared different questions on
KP showed that this deﬁnition is the most speciﬁc (72.7%) but
least sensitive (45.4%) predictor of disability because of KP.
However, applying a different KP deﬁnition would lead to a
different decision threshold. Fourthly, pain, USSCs and RKOA were
measured at one time point and longer follow-up with repeat
measures might have allowed better discrimination and predic-
tive value. Fifthly, diagnostic accuracy is affected by the charac-
teristics of the population in which the test accuracy is evaluated
such as the disease prevalence or the spectrum of the disease.
Further validation is needed when attempting to use the refer-
ence intervals and decision limit produced from this study.
Furthermore, we used KP plus RKOA as our reference standard to
deﬁne cases and control. Whether this is an adequate “gold
standard” for the USSCs examined requires further investigation.
It is suggested that the three USSCs are all features of “synovitis”.
However, KP is not only caused by “synovitis” and RKOA is often
asymptomatic and non-inﬂammatory. The large overlapping be-
tween cases and controls for the USSCs may suggest that our
reference standard needs to be improved. Further study using
MRI synovitis as a reference standard may be useful.
In summary, this study suggests that effusion and synovial
hypertrophy but not PDS are common in the general population
including people without KP and RKOA. Different thresholds for
both effusion and synovial hypertrophy should be applied for
men and women. These data are useful for the classiﬁcation of
synovial abnormalities in people with symptomatic RKOA, and
the development/revision of evidence based guidelines such as
the EULAR recommendations for the US abnormalities in knee
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